Relevance of Cardiovascular Exercise in Cancer and Cancer Therapy-Related Cardiac Dysfunction

Overview

Journal Curr Heart Fail Rep

Publisher Current Science

Date 2024 May 2

PMID 38696059

Authors

Simon Wernhart

Tienush Rassaf

Affiliations

Soon will be listed here.

Abstract

Purpose Of The Review: Cancer therapy-related cardiac dysfunction (CTRCD) has been identified as a threat to overall and cancer-related survival. Although aerobic exercise training (AET) has been shown to improve cardiorespiratory fitness (CRF), the relationship between specific exercise regimens and cancer survival, heart failure development, and reduction of CTRCD is unclear. In this review, we discuss the impact of AET on molecular pathways and the current literature of sports in the field of cardio-oncology.

Recent Findings: Cardio-oncological exercise trials have focused on variations of AET intensity by using moderate continuous and high intensity interval training, which are applicable, safe, and effective approaches to improve CRF. AET increases CRF, reduces cardiovascular morbidity and heart failure hospitalization and should thus be implemented as an adjunct to standard cancer therapy, although its long-term effect on CTRCD remains unknown. Despite modulating diverse molecular pathways, it remains unknown which exercise regimen, including variations of AET duration and frequency, is most suited to facilitate peripheral and central adaptations to exercise and improve survival in cancer patients.

Citing Articles

Effects of sex and obesity on immune checkpoint inhibition-related cardiac systolic dysfunction in aged mice.

Sayour N, Kucsera D, Alhaddad A, Toth V, Gergely T, Kovacs T Basic Res Cardiol. 2024; 120(1):207-223.

PMID: 39516409 PMC: 11790738. DOI: 10.1007/s00395-024-01088-4.

Prehabilitation for patients undergoing neoadjuvant therapy prior to cancer resection: a systematic review and meta-analysis.

Chen Y, Sebio-Garcia R, Iglesias-Garcia E, Reguart N, Martinez-Palli G, Bello I Support Care Cancer. 2024; 32(11):749.

PMID: 39466349 DOI: 10.1007/s00520-024-08941-1.

Cardioprotection of voluntary exercise against breast cancer-induced cardiac injury via STAT3.

Wu L, Li Z, Yang H, Cao L, Wang X, Wang D Basic Res Cardiol. 2024; 120(1):113-131.

PMID: 39158697 DOI: 10.1007/s00395-024-01076-8.

Cardiovascular mortality in people with cancer compared to the general population: A systematic review and meta-analysis.

Ng H, Meng R, Marin T, Damarell R, Buckley E, Selvanayagam J Cancer Med. 2024; 13(15):e70057.

PMID: 39096123 PMC: 11297437. DOI: 10.1002/cam4.70057.

Accuracy of the 6-Minute Walk Test for Assessing Functional Capacity in Patients With Heart Failure With Preserved Ejection Fraction and Other Chronic Cardiac Pathologies: Results of the ExIC-FEp Trial and a Meta-Analysis.

Cavero-Redondo I, Saz-Lara A, Bizzozero-Peroni B, Nunez-Martinez L, Diaz-Goni V, Calero-Paniagua I Sports Med Open. 2024; 10(1):74.

PMID: 38886304 PMC: 11183033. DOI: 10.1186/s40798-024-00740-6.

References

Fornaro A, Olivotto I, Rigacci L, Ciaccheri M, Tomberli B, Ferrantini C . Comparison of long-term outcome in anthracycline-related versus idiopathic dilated cardiomyopathy: a single centre experience. Eur J Heart Fail. 2017; 20(5):898-906. DOI: 10.1002/ejhf.1049. View

Irrcher I, Ljubicic V, Hood D . Interactions between ROS and AMP kinase activity in the regulation of PGC-1alpha transcription in skeletal muscle cells. Am J Physiol Cell Physiol. 2008; 296(1):C116-23. DOI: 10.1152/ajpcell.00267.2007. View

Gomes Neto M, Duraes A, Conceicao L, Saquetto M, Ellingsen O, Carvalho V . High intensity interval training versus moderate intensity continuous training on exercise capacity and quality of life in patients with heart failure with reduced ejection fraction: A systematic review and meta-analysis. Int J Cardiol. 2018; 261:134-141. DOI: 10.1016/j.ijcard.2018.02.076. View

Wernhart S, Papathanasiou M, Mahabadi A, Rassaf T, Luedike P . Betablockers reduce oxygen pulse increase and performance in heart failure patients with preserved ejection fraction. Int J Cardiol. 2022; 370:309-318. DOI: 10.1016/j.ijcard.2022.10.009. View

Lenk K, Erbs S, Hollriegel R, Beck E, Linke A, Gielen S . Exercise training leads to a reduction of elevated myostatin levels in patients with chronic heart failure. Eur J Prev Cardiol. 2011; 19(3):404-11. DOI: 10.1177/1741826711402735. View

Totzeck M, Mincu R, Mrotzek S, Schadendorf D, Rassaf T . Cardiovascular diseases in patients receiving small molecules with anti-vascular endothelial growth factor activity: A meta-analysis of approximately 29,000 cancer patients. Eur J Prev Cardiol. 2018; 25(5):482-494. DOI: 10.1177/2047487318755193. View

Yoon H, Kim K, Kim H, Park H, Cho J, Hong Y . Impacts of non-recovery of trastuzumab-induced cardiomyopathy on clinical outcomes in patients with breast cancer. Clin Res Cardiol. 2019; 108(8):892-900. DOI: 10.1007/s00392-019-01417-x. View

Cardinale D, Colombo A, Bacchiani G, Tedeschi I, Meroni C, Veglia F . Early detection of anthracycline cardiotoxicity and improvement with heart failure therapy. Circulation. 2015; 131(22):1981-8. DOI: 10.1161/CIRCULATIONAHA.114.013777. View

Zong W, Rabinowitz J, White E . Mitochondria and Cancer. Mol Cell. 2016; 61(5):667-676. PMC: 4779192. DOI: 10.1016/j.molcel.2016.02.011. View

10.

Totzeck M, Schuler M, Stuschke M, Heusch G, Rassaf T . Cardio-oncology - strategies for management of cancer-therapy related cardiovascular disease. Int J Cardiol. 2019; 280:163-175. DOI: 10.1016/j.ijcard.2019.01.038. View

11.

Jones L, Douglas P, Khouri M, Mackey J, Wojdyla D, Kraus W . Safety and efficacy of aerobic training in patients with cancer who have heart failure: an analysis of the HF-ACTION randomized trial. J Clin Oncol. 2014; 32(23):2496-502. PMC: 4121507. DOI: 10.1200/JCO.2013.53.5724. View

12.

Mousavi N, Tan T, Ali M, Halpern E, Wang L, Scherrer-Crosbie M . Echocardiographic parameters of left ventricular size and function as predictors of symptomatic heart failure in patients with a left ventricular ejection fraction of 50-59% treated with anthracyclines. Eur Heart J Cardiovasc Imaging. 2015; 16(9):977-84. DOI: 10.1093/ehjci/jev113. View

13.

Jones L, Fels D, West M, Allen J, Broadwater G, Barry W . Modulation of circulating angiogenic factors and tumor biology by aerobic training in breast cancer patients receiving neoadjuvant chemotherapy. Cancer Prev Res (Phila). 2013; 6(9):925-37. PMC: 3800005. DOI: 10.1158/1940-6207.CAPR-12-0416. View

14.

Hasenfuss G, Reinecke H, Studer R, Meyer M, Pieske B, Holtz J . Relation between myocardial function and expression of sarcoplasmic reticulum Ca(2+)-ATPase in failing and nonfailing human myocardium. Circ Res. 1994; 75(3):434-42. DOI: 10.1161/01.res.75.3.434. View

15.

Guazzi M, Wilhelm M, Halle M, Van Craenenbroeck E, Kemps H, de Boer R . Exercise testing in heart failure with preserved ejection fraction: an appraisal through diagnosis, pathophysiology and therapy - A clinical consensus statement of the Heart Failure Association and European Association of Preventive Cardiology of.... Eur J Heart Fail. 2022; 24(8):1327-1345. PMC: 9542249. DOI: 10.1002/ejhf.2601. View

16.

Okwuosa T, Ray R, Palomo A, Foraker R, Johnson L, Paskett E . Pre-Diagnosis Exercise and Cardiovascular Events in Primary Breast Cancer: Women's Health Initiative. JACC CardioOncol. 2021; 1(1):41-50. PMC: 8352124. DOI: 10.1016/j.jaccao.2019.08.014. View

17.

Wisloff U, Stoylen A, Loennechen J, Bruvold M, Rognmo O, Haram P . Superior cardiovascular effect of aerobic interval training versus moderate continuous training in heart failure patients: a randomized study. Circulation. 2007; 115(24):3086-94. DOI: 10.1161/CIRCULATIONAHA.106.675041. View

18.

DAscenzi F, Anselmi F, Fiorentini C, Mannucci R, Bonifazi M, Mondillo S . The benefits of exercise in cancer patients and the criteria for exercise prescription in cardio-oncology. Eur J Prev Cardiol. 2019; 28(7):725-735. DOI: 10.1177/2047487319874900. View

19.

Herrmann J, Lerman A, Sandhu N, Villarraga H, Mulvagh S, Kohli M . Evaluation and management of patients with heart disease and cancer: cardio-oncology. Mayo Clin Proc. 2014; 89(9):1287-306. PMC: 4258909. DOI: 10.1016/j.mayocp.2014.05.013. View

20.

Montero D, Diaz-Canestro C, Lundby C . Endurance Training and V˙O2max: Role of Maximal Cardiac Output and Oxygen Extraction. Med Sci Sports Exerc. 2015; 47(10):2024-33. DOI: 10.1249/MSS.0000000000000640. View